Oxoid Limited: Device Recall
Recall #Z-1075-2025 · 12/23/2024
Class II: Risk
Recall Details
- Recall Number
- Z-1075-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Oxoid Limited
- Status
- Ongoing
- Date Initiated
- 12/23/2024
- Location
- Basingstoke, United Kingdom
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1406 units
Reason for Recall
Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Product Description
Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797
Distribution Pattern
US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.